Table 1. Donor, transplant and recipient charachteristics in 184 retransplantations as continuous or discrete data.
| Continuous Variables | n | mean±SD |
| DONOR | ||
| Age (years) | 184 | 45±16 |
| AST/GOT (IU/L) | 154 | 60±64 |
| ALT/GPT (IU/L) | 157 | 43±48 |
| Gamma GT (IU/L) | 123 | 46±63 |
| Na (mEq/L) | 155 | 147±8 |
| TRANSPLANT | ||
| Ischemia time (hours) | 184 | 7.5±2.5 |
| RECIPIENT | ||
| Age | 184 | 48±12 |
| Creatinine R (mg/dL) | 134 | 1.7±1.1 |
| Bilirubin R (mg/dL) | 137 | 17.6±15.3 |
| INR R | 127 | 1,7±0,7 |
| MELD Score | 132 | 24±8 |
| AST/GOT R (UI/L) | 97 | 742±1615 |
| ALT/GPT R (UI/L) | 120 | 736±1354 |
| Albumin R (g/dL) | 66 | 3±0,5 |
| Platelets R | 118 | 90.847±76890 |
| Categorical Variables | n | % |
| DONOR | ||
| Gender | 184 | |
| M | 102 | 56 |
| F | 82 | 44 |
| TRANSPLANT | ||
| Graft | 184 | |
| Whole | 170 | 97 |
| Partial | 14 | 3 |
| ECC | 113 | |
| yes | 20 | 17 |
| no | 93 | 83 |
| RECIPIENT | ||
| Gender | 184 | |
| M | 131 | 71 |
| F | 53 | 28 |
| Indication 1st LT | 167 | |
| Virus rel. cirrhosis | 76 | 45 |
| Alcoholic cirrh. | 9 | 5 |
| Colestatic cirrh. | 15 | 9 |
| HCC | 23 | 14 |
| FHF | 8 | 5 |
| Other | 34 | 20 |
| Missing | 2 | 1 |
| Indication RETX | 184 | |
| HAT | 42 | 22 |
| PNF | 49 | 26 |
| Rejection | 6 | 3 |
| Recurrence | 10 | 5 |
| HCV recurrence | 19 | 10 |
| Other | 26 | 14 |
| Missing | 32 | 17 |
| Days from previous LT | 184 | |
| 0–8 | 52 | 28 |
| 8–30 | 37 | 20 |
| 31–180 | 36 | 19 |
| 181–365 | 12 | 6 |
| 366+ | 47 | 25 |
| MELD Score | 132 | |
| <15 | 22 | 16 |
| 16–24 | 42 | 32 |
| 25+ | 68 | 52 |
| Previous Graft | 183 | |
| Whole | 144 | 78 |
| Other | 39 | 21 |
| Status UNOS | 184 | |
| 1 | 72 | 39 |
| 2a | 80 | 43 |
| 2b | 23 | 12 |
| 3 | 9 | 5 |
AST means serum glutamic oxaloacetic transaminase; ALT, alanine transaminase; ECC, Extracorporeal circulation; LT, Liver Transplantation; HCC, Hepatocarcinoma; FHF, Fulminant Hepatic Failure; HAT, Hepatic Artery Thrombosis; PNF, Primary non Function; HCV, hepatitis C Virus; INR, International Normalized Ratio; MELD, Mayo End stage Liver Disease; UNOS, United Network for Organ Sharing.